These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 10780903)
1. Study on selectin blocker. 8. Lead discovery of a non-sugar antagonist using a 3D-pharmacophore model. Hiramatsu Y; Tsukida T; Nakai Y; Inoue Y; Kondo H J Med Chem; 2000 Apr; 43(8):1476-83. PubMed ID: 10780903 [TBL] [Abstract][Full Text] [Related]
2. Studies on selectin blocker. 9. SARs of non-sugar selectin blocker against E-, P-, L-selectin bindings. Moriyama H; Hiramatsu Y; Kiyoi T; Achiha T; Inoue Y; Kondo H Bioorg Med Chem; 2001 Jun; 9(6):1479-91. PubMed ID: 11408166 [TBL] [Abstract][Full Text] [Related]
3. Studies on selectin blockers. 7. Structure-activity relationships of sialyl Lewis X mimetics based on modified Ser-Glu dipeptides. Tsukida T; Moriyama H; Kurokawa K; Achiha T; Inoue Y; Kondo H J Med Chem; 1998 Oct; 41(22):4279-87. PubMed ID: 9784103 [TBL] [Abstract][Full Text] [Related]
4. Studies on selectin blockers. 6. Discovery of homologous fucose sugar unit necessary for E-selectin binding. Hiramatsu Y; Moriyama H; Kiyoi T; Tsukida T; Inoue Y; Kondo H J Med Chem; 1998 Jun; 41(13):2302-7. PubMed ID: 9632363 [TBL] [Abstract][Full Text] [Related]
5. Identification of a novel carbohydrate-mimicking octapeptide from chemical peptide library and characterization as selectin inhibitor. Kawano S; Iyaguchi D; Sasaki Y; Sekizaki H; Toyota E Biol Pharm Bull; 2011; 34(6):883-9. PubMed ID: 21628888 [TBL] [Abstract][Full Text] [Related]
6. Application of homonuclear 3D NMR experiments and 1D analogs to study the conformation of sialyl Lewis(x) bound to E-selectin. Scheffler K; Brisson JR; Weisemann R; Magnani JL; Wong WT; Ernst B; Peters T J Biomol NMR; 1997 Jun; 9(4):423-36. PubMed ID: 9255946 [TBL] [Abstract][Full Text] [Related]
7. Selectin-ligand interactions revealed by molecular dynamics simulation in solution. Tsujishita H; Hiramatsu Y; Kondo N; Ohmoto H; Kondo H; Kiso M; Hasegawa A J Med Chem; 1997 Jan; 40(3):362-9. PubMed ID: 9022803 [TBL] [Abstract][Full Text] [Related]
8. Studies on selectin blockers. 4. Structure-function relationships of sulfated sialyl Lewis X hexasaccharide ceramides toward E-, P-, and L-selectin binding. Yoshino K; Ohmoto H; Kondo N; Tsujishita H; Hiramatsu Y; Inoue Y; Kondo H J Med Chem; 1997 Feb; 40(4):455-62. PubMed ID: 9046335 [TBL] [Abstract][Full Text] [Related]
9. Structure of a selectin-like mutant of mannose-binding protein complexed with sialylated and sulfated Lewis(x) oligosaccharides. Ng KK; Weis WI Biochemistry; 1997 Feb; 36(5):979-88. PubMed ID: 9033386 [TBL] [Abstract][Full Text] [Related]
10. Probing the carbohydrate recognition domain of E-selectin: the importance of the acid orientation in sLex mimetics. Titz A; Patton J; Smiesko M; Radic Z; Schwardt O; Magnani JL; Ernst B Bioorg Med Chem; 2010 Jan; 18(1):19-27. PubMed ID: 19948406 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of sialyl Lewis X pentasaccharide analogue for high-throughput screening of selectin blockers. Kiyoi T; Inoue Y; Ohmoto H; Yoshida M; Kiso M; Kondo H Bioorg Med Chem; 1998 May; 6(5):587-93. PubMed ID: 9629472 [TBL] [Abstract][Full Text] [Related]
12. Computational modeling of carbohydrate-recognition process in E-selectin complex: structural mapping of sialyl Lewis X onto ab initio QM/MM free energy surface. Ishida T J Phys Chem B; 2010 Mar; 114(11):3950-64. PubMed ID: 20078087 [TBL] [Abstract][Full Text] [Related]
13. Studies on selectin blockers. 2. Novel selectin blocker as potential therapeutics for inflammatory disorders. Wada Y; Saito T; Matsuda N; Ohmoto H; Yoshino K; Ohashi M; Kondo H; Ishida H; Kiso M; Hasegawa A J Med Chem; 1996 May; 39(10):2055-9. PubMed ID: 8642564 [TBL] [Abstract][Full Text] [Related]
14. Comparison of human and mouse E-selectin binding to Sialyl-Lewis(x). Rocheleau AD; Cao TM; Takitani T; King MR BMC Struct Biol; 2016 Jul; 16(1):10. PubMed ID: 27368167 [TBL] [Abstract][Full Text] [Related]
15. Synergistic interactions of the two classes of ligand, sialyl-Lewis(a/x) fuco-oligosaccharides and short sulpho-motifs, with the P- and L-selectins: implications for therapeutic inhibitor designs. Galustian C; Childs RA; Stoll M; Ishida H; Kiso M; Feizi T Immunology; 2002 Mar; 105(3):350-9. PubMed ID: 11918697 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of a potent E-selectin antagonist. Thoma G; Kinzy W; Bruns C; Patton JT; Magnani JL; Bänteli R J Med Chem; 1999 Nov; 42(23):4909-13. PubMed ID: 10579852 [TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of sialyl Lewis(x) mimics as E- and P-selectin inhibitors. Kaila N; Thomas BE Med Res Rev; 2002 Nov; 22(6):566-601. PubMed ID: 12369089 [TBL] [Abstract][Full Text] [Related]
18. The three members of the selectin receptor family recognize a common carbohydrate epitope, the sialyl Lewis(x) oligosaccharide. Foxall C; Watson SR; Dowbenko D; Fennie C; Lasky LA; Kiso M; Hasegawa A; Asa D; Brandley BK J Cell Biol; 1992 May; 117(4):895-902. PubMed ID: 1374413 [TBL] [Abstract][Full Text] [Related]
19. P- and E-selectins recognize sialyl 6-sulfo Lewis X, the recently identified L-selectin ligand. Ohmori K; Kanda K; Mitsuoka C; Kanamori A; Kurata-Miura K; Sasaki K; Nishi T; Tamatani T; Kannagi R Biochem Biophys Res Commun; 2000 Nov; 278(1):90-6. PubMed ID: 11071860 [TBL] [Abstract][Full Text] [Related]
20. Affinity and kinetics of sialyl Lewis-X and core-2 based oligosaccharides binding to L- and P-selectin. Beauharnois ME; Lindquist KC; Marathe D; Vanderslice P; Xia J; Matta KL; Neelamegham S Biochemistry; 2005 Jul; 44(27):9507-19. PubMed ID: 15996105 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]